Company: HRTX
Filing Date: 2025-05-06
Form Type: 8-K
Source: 0000950170-25-063973
Chunk: 0

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-05-06
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

On May 6, 2025, Heron Therapeutics, Inc. (“ Company”) issued a press release announcing its financial results for the three months ended March 31, 2025 (“ Earnings Press Release”). A copy of the Earnings Press Release is furnished as Exhibit 99.1.

The information in this Item 2.02 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.